Lack of evidence from studies of soluble protein fragments that knops blood group polymorphisms in complement receptor-type 1 are driven by malaria

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Tetteh Quarcoo, Patience B ^a   Schmidt, Christoph Q ^a   Tham, Wai Hong ^b   Hauhart, Richard ^c   Mertens, Haydyn D T ^d   Rowe, Arthur ^e   Atkinson, John P ^c   Cowman, Alan F ^b   Rowe, J Alexandra ^a   Barlow, Paul N ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d AUSTRALIAN SYNCHROTRON   (Australia)

^e UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C3B; COMPLEMENT COMPONENT C3B RECEPTOR; COMPLEMENT COMPONENT C4B; OPSONIN; BLOOD GROUP ANTIGEN; COMPLEMENT RECEPTOR;

ANTIGEN RECOGNITION; ANTIGENIC VARIATION; ARTICLE; BINDING AFFINITY; CELL INVASION; COMPLEMENT SYSTEM; CONTROLLED STUDY; CR1 GENE; ERYTHROCYTE; GENE; GENE CONTROL; GENE FUNCTION; GENE IDENTIFICATION; GENE STRUCTURE; GENETIC POLYMORPHISM; GENOMIC FRAGMENT; HOST PARASITE INTERACTION; HUMAN; HUMAN CELL; MALARIA; MOLECULAR STABILITY; NONHUMAN; PLASMODIUM FALCIPARUM; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN CLEAVAGE; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN IMMOBILIZATION; PROTEIN PROTEIN INTERACTION; ALLELE; ANIMAL; BLOOD; GENETICS; METABOLISM; PARASITE; PICHIA;

PLASMODIUM FALCIPARUM;

ALLELES; ANIMALS; BLOOD GROUP ANTIGENS; COMPLEMENT C3B; COMPLEMENT C4B; ERYTHROCYTES; HUMANS; MALARIA; PARASITES; PICHIA; PLASMODIUM FALCIPARUM; POLYMORPHISM, GENETIC; RECEPTORS, COMPLEMENT;

EID: 84859616973     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0034820     Document Type: Article

References (65)

1. Moulds JM, (2002) A review of the Knops blood group: separating fact from fallacy. Immunohematology 18: 1-8.
2. Moulds JM, (2010) The Knops blood-group system: a review. Immunohematology 26: 2-7.
3. Moulds JM, Zimmerman PA, Doumbo OK, Kassambara L, Sagara I, et al. (2001) Molecular identification of Knops blood group polymorphisms found in long homologous region D of complement receptor 1. Blood 97: 2879-2885.
4. Rowe JA, Opi DH, Williams TN, (2009) Blood groups and malaria: fresh insights into pathogenesis and identification of targets for intervention. Curr Opin Hematol 16: 480-487.
5. Stoute JA, (2005) Complement-regulatory proteins in severe malaria: too little or too much of a good thing? Trends Parasitol 21: 218-223.
6. Reid ME, (2004) The blood group antigen. Facts Book London Elsevier Academic Press.
7. Stoute JA, (2011) Complement receptor 1 and malaria. Cell Microbiol 13: 1441-50.
8. Murray CJ, Rosenfeld LC, Lim SS, Andrews KG, Foreman KJ, et al. (2012) Global malaria mortality between 1980 and 2010: a systematic analysis. Lancet 379: 413-431.
9. Spadafora C, Awandare GA, Kopydlowski KM, Czege J, Moch JK, et al. (2010) Complement receptor 1 is a sialic acid-independent erythrocyte receptor of Plasmodium falciparum. PLoS Pathog 6: e1000968.
10. Awandare GA, Spadafora C, Moch JK, Dutta S, Haynes JD, et al. (2011) Plasmodium falciparum field isolates use complement receptor 1 (CR1) as a receptor for invasion of erythrocytes. Mol Biochem Parasitol 177: 57-60.
11. Tham WH, Wilson DW, Lopaticki S, Schmidt CQ, Tetteh-Quarcoo PB, et al. (2010) Complement receptor 1 is the host erythrocyte receptor for Plasmodium falciparum PfRh4 invasion ligand. Proc Natl Acad Sci U S A 107: 17327-17332.
12. Rowe JA, Moulds JM, Newbold CI, Miller LH, (1997) P. falciparum rosetting mediated by a parasite-variant erythrocyte membrane protein and complement-receptor 1. Nature 388: 292-295.
13. Doumbo OK, Thera MA, Kone AK, Raza A, Tempest LJ, et al. (2009) High levels of Plasmodium falciparum rosetting in all clinical forms of severe malaria in African children. Am J Trop Med Hyg 81: 987-993.
14. Thathy V, Moulds JM, Guyah B, Otieno W, Stoute JA, (2005) Complement receptor 1 polymorphisms associated with resistance to severe malaria in Kenya. Malar J 4: 54.
15. Zimmerman PA, Fitness J, Moulds JM, McNamara DT, Kasehagen LJ, et al. (2003) CR1 Knops blood group alleles are not associated with severe malaria in the Gambia. Genes Immun 4: 368-373.
16. Jallow M, Teo YY, Small KS, Rockett KA, Deloukas P, et al. (2009) Genome-wide and fine-resolution association analysis of malaria in West Africa. Nat Genet 41: 657-665.
17. Krych-Goldberg M, Atkinson JP, (2001) Structure-function relationships of complement receptor type 1. Immunol Rev 180: 112-122.
18. Birmingham DJ, (1995) Erythrocyte complement receptors. Crit Rev Immunol 15: 133-154.
19. Klickstein LB, Wong WW, Smith JA, Weis JH, Wilson JG, et al. (1987) Human C3b/C4b receptor (CR1). Demonstration of long homologous repeating domains that are composed of the short consensus repeats characteristics of C3/C4 binding proteins. J Exp Med 165: 1095-1112.
20. Krych M, Hourcade D, Atkinson JP, (1991) Sites within the complement C3b/C4b receptor important for the specificity of ligand binding. Proc Natl Acad Sci U S A 88: 4353-4357.
21. Krych M, Clemenza L, Howdeshell D, Hauhart R, Hourcade D, et al. (1994) Analysis of the functional domains of complement receptor type 1 (C3b/C4b receptor; CD35) by substitution mutagenesis. J Biol Chem 269: 13273-13278.
22. Subramanian VB, Clemenza L, Krych M, Atkinson JP, (1996) Substitution of two amino acids confers C3b binding to the C4b binding site of CR1 (CD35). Analysis based on ligand binding by chimpanzee erythrocyte complement receptor. J Immunol 157: 1242-1247.
23. Krych M, Hauhart R, Atkinson JP, (1998) Structure-function analysis of the active sites of complement receptor type 1. J Biol Chem 273: 8623-8629.
24. Krych-Goldberg M, Hauhart RE, Porzukowiak T, Atkinson JP, (2005) Synergy between two active sites of human complement receptor type 1 (CD35) in complement regulation: implications for the structure of the classical pathway C3 convertase and generation of more potent inhibitors. J Immunol 175: 4528-4535.
25. Ricklin D, Hajishengallis G, Yang K, Lambris JD, (2010) Complement: a key system for immune surveillance and homeostasis. Nat Immunol 11: 785-797.
26. Tham WH, Schmidt CQ, Hauhart RE, Guariento M, Tetteh-Quarcoo PB, et al. (2011) Plasmodium falciparum uses a key functional site in complement receptor type-1 for invasion of human erythrocytes. Blood 118: 1923-1933.
27. Rowe JA, Rogerson SJ, Raza A, Moulds JM, Kazatchkine MD, et al. (2000) Mapping of the region of complement receptor (CR) 1 required for Plasmodium falciparum rosetting and demonstration of the importance of CR1 in rosetting in field isolates. J Immunol 165: 6341-6346.
28. Weisman HF, Bartow T, Leppo MK, Marsh HC Jr, Carson GR, et al. (1990) Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. Science 249: 146-151.
29. Kirkitadze MD, Dryden DT, Kelly SM, Price NC, Wang X, et al. (1999) Co-operativity between modules within a C3b-binding site of complement receptor type 1. FEBS Lett 459: 133-138.
30. Kirkitadze MD, Krych M, Uhrin D, Dryden DT, Smith BO, et al. (1999) Independently melting modules and highly structured intermodular junctions within complement receptor type 1. Biochemistry 38: 7019-7031.
31. Furtado PB, Huang CY, Ihyembe D, Hammond RA, Marsh HC, et al. (2008) The partly folded back solution structure arrangement of the 30 SCR domains in human complement receptor type 1 (CR1) permits access to its C3b and C4b ligands. J Mol Biol 375: 102-118.
32. Klickstein LB, Barbashov SF, Liu T, Jack RM, Nicholson-Weller A, (1997) Complement receptor type 1 (CR1, CD35) is a receptor for C1q. Immunity 7: 345-355.
33. Schmidt CQ, Slingsby FC, Richards A, Barlow PN, (2011) Production of biologically active complement factor H in therapeutically useful quantities. Protein Expr Purif 76: 254-263.
34. Schmidt CQ, Herbert AP, Mertens HD, Guariento M, Soares DC, et al. (2010) The central portion of factor H (modules 10-15) is compact and contains a structurally deviant CCP module. J Mol Biol 395: 105-122.
35. Roversi P, Johnson S, Caesar JJ, McLean F, Leath KJ, et al. (2011) Structural basis for complement factor I control and its disease-associated sequence polymorphisms. Proc Natl Acad Sci U S A 108: 12839-12844.
36. Tas SW, Klickstein LB, Barbashov SF, Nicholson-Weller A, (1999) C1q and C4b bind simultaneously to CR1 and additively support erythrocyte adhesion. J Immunol 163: 5056-5063.
37. Ghiran I, Barbashov SF, Klickstein LB, Tas SW, Jensenius JC, et al. (2000) Complement receptor 1/CD35 is a receptor for mannan-binding lectin. J Exp Med 192: 1797-1808.
38. Tham WH, Wilson DW, Reiling L, Chen L, Beeson JG, et al. (2009) Antibodies to reticulocyte binding protein-like homologue 4 inhibit invasion of Plasmodium falciparum into human erythrocytes. Infect Immun 77: 2427-2435.
39. Ghumra A, Khunrae P, Ataide R, Raza A, Rogerson SJ, et al. (2011) Immunisation with recombinant PfEMP1 domains elicits functional rosette-inhibiting and phagocytosis-inducing antibodies to Plasmodium falciparum. PLoS One 6: e16414.
40. Bjorklund AK, Ekman D, Elofsson A, (2006) Expansion of protein domain repeats. PLoS Comput Biol 2: e114.
41. Barlow PN, Baron M, Norman DG, Day AJ, Willis AC, et al. (1991) Secondary structure of a complement control protein module by two-dimensional 1H NMR. Biochemistry 30: 997-1004.
42. Norman DG, Barlow PN, Baron M, Day AJ, Sim RB, et al. (1991) Three-dimensional structure of a complement control protein module in solution. J Mol Biol 219: 717-725.
43. Soares DC, Gerloff DL, Syme NR, Coulson AF, Parkinson J, et al. (2005) Large-scale modelling as a route to multiple surface comparisons of the CCP module family. Protein Eng Des Sel 18: 379-388. Epub 2005 Jun 2023.
44. Wu J, Wu YQ, Ricklin D, Janssen BJ, Lambris JD, et al. (2009) Structure of complement fragment C3b-factor H and implications for host protection by complement regulators. Nat Immunol 10: 728-733.
45. Krych M, Atkinson JP, Holers VM, (1992) Complement receptors. Curr Opin Immunol 4: 8-13.
46. Fearon DT, Klickstein LB, Wong WW, Wilson JG, Moore FD Jr, et al. (1989) Immunoregulatory functions of complement: structural and functional studies of complement receptor type 1 (CR1; CD35) and type 2 (CR2; CD21). Prog Clin Biol Res 297: 211-220.
47. Ghiran I, Glodek AM, Weaver G, Klickstein LB, Nicholson-Weller A, (2008) Ligation of erythrocyte CR1 induces its clustering in complex with scaffolding protein FAP-1. Blood 112: 3465-3473.
48. Rowe JA, Raza A, Diallo DA, Baby M, Poudiougo B, et al. (2002) Erythrocyte CR1 expression level does not correlate with a HindIII restriction fragment length polymorphism in Africans; implications for studies on malaria susceptibility. Genes Immun 3: 497-500.
49. Noumsi GT, Tounkara A, Diallo H, Billingsley K, Moulds JJ, et al. (2011) Knops blood group polymorphism and susceptibility to Mycobacterium tuberculosis infection. Transfusion 51: 2462-2469.
50. Vranken WF, Boucher W, Stevens TJ, Fogh RH, Pajon A, et al. (2005) The CCPN data model for NMR spectroscopy: development of a software pipeline. Proteins 59: 687-696.
51. Grzesiek S, Bax A, (1993) Amino-Acid Type Determination in the Sequential Assignment Procedure of Uniformly C-13/N-15-Enriched Proteins. Journal of Biomolecular Nmr 3: 185-204.
52. Schuck P, (2000) Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and Lamm equation modeling. Biophysical Journal 78: 1606-1619.
53. Laue TM, Shah BD, Ridgeway TM, Pelletier SL, (1992) Computer-aided interpretation of analytical sedimentation data for proteins. In: Harding SE, Rowe AJ, Horton JC, editors. Analytical Ultracentrifugation in Biochemistry and Polymer Science Cambridge, United Kingdom Royal Society for Chemistry pp. 90-125.
54. Koch MHJ, Bordas J, (1983) X-Ray-Diffraction and Scattering on Disordered-Systems Using Synchrotron Radiation. Nuclear Instruments & Methods in Physics Research 208: 461-469.
55. Roessle MW, Klaering R, Ristau U, Robrahn B, Jahn D, et al. (2007) Upgrade of the small-angle X-ray scattering beamline ×33 at the European Molecular Biology Laboratory, Hamburg. Journal of Applied Crystallography 40: S190-S194.
56. Konarev PV, Volkov VV, Sokolova AV, Koch MHJ, Svergun DI, (2003) PRIMUS: a Windows PC-based system for small-angle scattering data analysis. Journal of Applied Crystallography 36: 1277-1282.
57. Guinier A, (1939) La diffraction des rayons X aux tres petits angles; application a l'etude de phenomenes ultramicroscopiques. Annals of Physics (Paris) 12: 161-237.
58. Svergun DI, (1992) Determination of the Regularization Parameter in Indirect-Transform Methods Using Perceptual Criteria. Journal of Applied Crystallography 25: 495-503.
59. Franke D, Svergun DI, (2009) DAMMIF, a program for rapid ab-initio shape determination in small-angle scattering. Journal of Applied Crystallography 42: 342-346.
60. Kozin MB, Svergun DI, (2001) Automated matching of high- and low-resolution structural models. Journal of Applied Crystallography 34: 33-41.
61. Volkov VV, Svergun DI, (2003) Uniqueness of ab initio shape determination in small-angle scattering. Journal of Applied Crystallography 36: 860-864.
62. Schmidt CQ, Herbert AP, Kavanagh D, Gandy C, Fenton CJ, et al. (2008) A new map of glycosaminoglycan and C3b binding sites on factor H. J Immunol 181: 2610-2619.
63. Stubbs J, Simpson KM, Triglia T, Plouffe D, Tonkin CJ, et al. (2005) Molecular mechanism for switching of P. falciparum invasion pathways into human erythrocytes. Science 309: 1384-1387.
64. Persson KE, McCallum FJ, Reiling L, Lister NA, Stubbs J, et al. (2008) Variation in use of erythrocyte invasion pathways by Plasmodium falciparum mediates evasion of human inhibitory antibodies. J Clin Invest 118: 342-351.
65. Corrigan RA, Rowe JA, (2010) Strain variation in early innate cytokine induction by Plasmodium falciparum. Parasite Immunol 32: 512-527.